CPRX

Catalyst Pharmaceuticals Inc

• NASDAQ·2d ago

  Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics

• NASDAQ·6d ago

  5 Small Drug Stocks to Buy as Sector Recovery Gains Strength

• NASDAQ·03/31 09:28

  New Strong Buy Stocks for March 31st

• NASDAQ·03/31 07:56

  Best Value Stocks to Buy for March 31st

• NASDAQ·03/27 15:30

  Catalyst (CPRX) Down 2.5% Since Last Earnings Report: Can It Rebound?

• NASDAQ·03/26 17:14

  SRPT Stock Surges on Promising Early Results From siRNA Programs

• Dow Jones·03/25 20:35

  Catalyst Pharmaceuticals Inc. Stock Advances 3.2%, Outperforms Peers

• NASDAQ·03/25 16:24

  NVO Eyes Global Expansion of Diabetes Drug After Strong Phase II Data

• NASDAQ·03/25 12:23

  IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims

• NASDAQ·03/24 16:12

  VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study

• NASDAQ·03/20 12:10

  FDA Approves Novo Nordisk's Higher-Dose Wegovy for Obesity Patients

• Reuters·03/19 10:04

  Catalyst Pharmaceuticals files 8-K/A to correct signature date on March 18, 2026 filing

• TipRanks·03/18 22:06

  Catalyst Pharma Patent Trial Against Hetero USA Delayed

• Benzinga·03/18 21:45

  Catalyst Pharmaceuticals Says District Court Delays Bench Trial To May 18, 2026; Bench Trial Concerns Validity Of FIRDAPSE Patents Expiring In 2032, 2034, 2037

• Reuters·03/18 21:22

  CATALYST PHARMACEUTICALS INC - BENCH TRIAL CONCERNS VALIDITY OF FIRDAPSE PATENTS EXPIRING IN 2032, 2034, 2037 - SEC FILING